Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Cell Death Differ ; 8(12): 1213-23, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11753569

RESUMEN

Inactivation of the tumour suppressor p53 is the most common defect in cancer cells. p53 is a sequence specific transcription factor that is activated in response to various forms of genotoxic stress to induce cell cycle arrest and apoptosis. Induction of p53 is subjected to complex and strict control through several pathways, as it will often determine cellular fate. The p73 protein shares strong structural and functional similarities with p53 such as the potential to activate p53 responsive genes and the ability to induce apoptosis. In addition to alternative splicing at the carboxyl terminus which yields several p73 isoforms, a p73 variant lacking the N-terminal transactivation domain (Delta Np73) was described in mice. In this study, we report the cloning and characterisation of the human Delta Np73 isoforms, their regulation by p53 and their possible role in carcinogenesis. As in mice, human Delta Np73 lacks the transactivation domain and starts with an alternative exon (exon 3'). Its expression is driven by a second promoter located in a genomic region upstream of this exon, supporting the idea of two independently regulated proteins, derived from the same gene. As anticipated, Delta Np73 is capable of regulating TAp73 and p53 function since it is able to block their transactivation activity and their ability to induce apoptosis. Interestingly, expression of the Delta Np73 is strongly up-regulated by the TA isoforms and by p53, thus creating a feedback loop that tightly regulates the function of TAp73 and more importantly of p53. The regulation of Delta Np73 is exerted through a p53 responsive element located on the Delta N promoter. Expression of Delta Np73 not only regulates the function of p53 and TAp73 but also shuts off its own expression, once again finely regulating the whole system. Our data also suggest that increased expression of Delta Np73, functionally inactivating p53, could be involved in tumorogenesis. An extensive analysis of the expression pattern of Delta Np73 in primary tumours would clarify this issue.


Asunto(s)
Proteínas de Unión al ADN/metabolismo , Genes p53 , Proteínas Nucleares/metabolismo , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Clonación de Organismos , Proteínas de Unión al ADN/genética , Retroalimentación Fisiológica , Regulación de la Expresión Génica , Genes Supresores de Tumor , Humanos , Intrones , Ratones , Datos de Secuencia Molecular , Proteínas Nucleares/genética , Fosfoproteínas Fosfatasas , Regiones Promotoras Genéticas , Activación Transcripcional/genética , Activación Transcripcional/fisiología , Transfección , Células Tumorales Cultivadas , Proteína Tumoral p73 , Proteínas Supresoras de Tumor
3.
Nat Cell Biol ; 3(9): 839-43, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11533664

RESUMEN

Heat-shock protein 70 (Hsp70) has been reported to block apoptosis by binding apoptosis protease activating factor-1 (Apaf-1), thereby preventing constitution of the apoptosome, the Apaf-1/cytochrome c/caspase-9 activation complex [1,2]. Here we show that overexpression of Hsp70 protects Apaf-1-/- cells against death induced by serum withdrawal, indicating that Apaf-1 is not the only target of the anti-apoptotic action of Hsp70. We investigated the effect of Hsp70 on apoptosis mediated by the caspase-independent death effector apoptosis inducing factor (AIF), which is a mitochondrial intermembrane flavoprotein [3,4]. In a cell-free system, Hsp70 prevented the AIF-induced chromatin condensation of purified nuclei. Hsp70 specifically interacted with AIF, as shown by ligand blots and co-immunoprecipitation. Cells overexpressing Hsp70 were protected against the apoptogenic effects of AIF targeted to the extramitochondrial compartment. In contrast, an anti-sense Hsp70 complementary DNA, which reduced the expression of endogenous Hsp70, increased sensitivity to the lethal effect of AIF. The ATP-binding domain of Hsp70 seemed to be dispensable for inhibiting cell death induced by serum withdrawal, AIF binding and AIF inhibition, although it was required for Apaf-1 binding. Together, our data indicate that Hsp70 can inhibit apoptosis by interfering with target proteins other than Apaf-1, one of which is AIF.


Asunto(s)
Apoptosis/fisiología , Fibroblastos/citología , Fibroblastos/fisiología , Flavoproteínas/metabolismo , Proteínas HSP70 de Choque Térmico/metabolismo , Proteínas de la Membrana/metabolismo , Proteínas/metabolismo , Animales , Factor Inductor de la Apoptosis , Factor Apoptótico 1 Activador de Proteasas , Núcleo Celular/ultraestructura , Supervivencia Celular , Células Cultivadas , Cromatina/fisiología , Cromatina/ultraestructura , Medio de Cultivo Libre de Suero , Flavoproteínas/genética , Proteínas de la Membrana/genética , Ratones , Proteínas/antagonistas & inhibidores , Proteínas/genética , Proteínas Recombinantes/metabolismo , Transfección
5.
Cell Death Differ ; 7(4): 368-73, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10773821

RESUMEN

Caspase activation may occur in a direct fashion as a result of CD95 death receptor crosslinking (exogenous pathway) or may be triggered indirectly, via a Bcl-2 inhibitable mitochondrial permeabilization event (endogenous pathway). Thymocyte apoptosis is generally accompanied by proteasome activation. If death is induced by DNA damage, inactivation of p53, overexpression of a Bcl-2 transgene, inhibition of protein synthesis, and antioxidants (N-acetylcyteine, catalase) prevent proteasome activation. Glucocorticoid-induced proteasome activation follows a similar pattern of inhibition except for p53. Caspase inhibition fails to affect proteasome activation induced by topoisomerase inhibition or glucocorticoid receptor ligation. In contrast, caspase activation (but not p53 knockout or Bcl-2 overexpression) does interfere with proteasome activation induced by CD95. Specific inhibition of proteasomes with lactacystin or MG123 blocks caspase activation at a pre-mitochondrial level if thymocyte apoptosis is induced by DNA damage or glucocorticoids. In strict contrast, proteasome inhibition has no inhibitory effect on the mitochondrial and nuclear phases of apoptosis induced via CD95. Thus, proteasome activation is a critical event of thymocyte apoptosis stimulated via the endogenous pathway yet dispensable for CD95-triggered death.


Asunto(s)
Apoptosis/fisiología , Cisteína Endopeptidasas/metabolismo , Complejos Multienzimáticos/metabolismo , Linfocitos T/fisiología , Receptor fas/fisiología , Acetilcisteína/farmacología , Clorometilcetonas de Aminoácidos/farmacología , Animales , Antioxidantes/farmacología , Apoptosis/efectos de los fármacos , Inhibidores de Caspasas , Caspasas/metabolismo , Catalasa/farmacología , Células Cultivadas , Cisteína Endopeptidasas/efectos de los fármacos , Dactinomicina/farmacología , Dexametasona/farmacología , Activación Enzimática , Etopósido/farmacología , Femenino , Ratones , Ratones Endogámicos BALB C , Mitocondrias/metabolismo , Complejos Multienzimáticos/efectos de los fármacos , Complejo de la Endopetidasa Proteasomal , Linfocitos T/citología , Linfocitos T/efectos de los fármacos
6.
Oncogene ; 19(54): 6342-50, 2000 Dec 14.
Artículo en Inglés | MEDLINE | ID: mdl-11175349

RESUMEN

Similar to most if not all pro-apoptotic members of the Bcl-2 family, Bid (and its truncated product t-Bid) triggers cell death via mitochondrial membrane permeabilization (MMP). This effect can be monitored in intact cells, upon microinjection of recombinant Bid protein into the cytoplasm, as well as in purified mitochondria, upon addition of Bid protein. Here we show that Bid-induced MMP can be inhibited, both in cells and in the cell-free system, by three pharmacological inhibitors of the permeability transition pore complex (PTPC), namely cyclosporin A, N-methyl-4-Val-cyclosporin A, and bongkrekic acid (a ligand of the adenine nucleotide translocase, ANT, one of the PTPC components). Bid effects on synthetic membranes were studied either in proteoliposomes or in synthetic bilayers subjected to electrophysiological measurements. Full length Bid preferentially permeabilizes membranes and induces the formation of large conductance channels at neutral pH, when added to liposomes or bilayers containing both purified ANT and Bax, yet has no or little effect combined with ANT or Bax alone. t-Bid acts on membranes containing ANT alone with the same efficiency as on those containing both ANT and Bax. These results suggest that the proapoptotic effects of Bid are mediated, at least in part, by its functional interaction with ANT, one of the major components of PTPC.


Asunto(s)
Apoptosis , Proteínas Portadoras/fisiología , Canales Iónicos , Proteínas de la Membrana/metabolismo , Mitocondrias/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2 , Animales , Proteína Proapoptótica que Interacciona Mediante Dominios BH3 , Ácido Bongcréquico/farmacología , Proteínas Portadoras/genética , Línea Celular , Ciclosporinas/farmacología , Conductividad Eléctrica , Membranas Intracelulares/metabolismo , Membrana Dobles de Lípidos/metabolismo , Liposomas/metabolismo , Proteínas de la Membrana/efectos de los fármacos , Microinyecciones , Mitocondrias/efectos de los fármacos , Translocasas Mitocondriales de ADP y ATP/metabolismo , Proteínas de Transporte de Membrana Mitocondrial , Poro de Transición de la Permeabilidad Mitocondrial , Permeabilidad/efectos de los fármacos , Porinas/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Ratas , Proteínas Recombinantes/metabolismo , Proteína X Asociada a bcl-2
7.
J Immunol ; 162(11): 6534-42, 1999 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-10352269

RESUMEN

Apoptosis is accompanied by major changes in ion compartmentalization and transmembrane potentials. Thymocyte apoptosis is characterized by an early dissipation of the mitochondrial transmembrane potential, with transient mitochondrial swelling and a subsequent loss of plasma membrane potential (DeltaP sip) related to the loss of cytosolic K+, cellular shrinkage, and DNA fragmentation. Thus, a gross perturbation of DeltaPsip occurs at the postmitochondrial stage of apoptosis. Unexpectedly, we found that blockade of plasma membrane K+ channels by tetrapentylammonium (TPA), which leads to a DeltaP sip collapse, can prevent the thymocyte apoptosis induced by exposure to the glucocorticoid receptor agonist dexamethasone, the topoisomerase inhibitor etoposide, gamma-irradiation, or ceramide. The TPA-mediated protective effect extends to all features of apoptosis, including dissipation of the mitochondrial transmembrane potential, loss of cytosolic K+, phosphatidylserine exposure on the cell surface, chromatin condensation, as well as caspase and endonuclease activation. In strict contrast, TPA is an ineffective inhibitor when cell death is induced by the potassium ionophore valinomycin, the specific mitochondrial benzodiazepine ligand PK11195, or by primary caspase activation by Fas/CD95 cross-linking. These results underline the importance of K+ channels for the regulation of some but not all pathways leading to thymocyte apoptosis.


Asunto(s)
Apoptosis/inmunología , Linfocitos T/fisiología , Timo/fisiología , Animales , Apoptosis/efectos de los fármacos , Apoptosis/fisiología , Membrana Celular/efectos de los fármacos , Membrana Celular/fisiología , Membrana Celular/ultraestructura , Dexametasona/farmacología , Etopósido/farmacología , Femenino , Membranas Intracelulares/efectos de los fármacos , Membranas Intracelulares/fisiología , Membranas Intracelulares/ultraestructura , Potenciales de la Membrana/inmunología , Ratones , Ratones Endogámicos BALB C , Mitocondrias/efectos de los fármacos , Mitocondrias/fisiología , Mitocondrias/ultraestructura , Bloqueadores de los Canales de Potasio , Transducción de Señal/inmunología , Linfocitos T/efectos de los fármacos , Linfocitos T/ultraestructura , Acetato de Tetradecanoilforbol/farmacología , Timo/efectos de los fármacos , Timo/ultraestructura
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA